Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.310
+0.060 (4.80%)
At close: Aug 13, 2025, 4:00 PM
1.390
+0.080 (6.11%)
Pre-market: Aug 14, 2025, 8:58 AM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $41.08 million as of August 14, 2025. Its market cap has decreased by -84.99% in one year.
Market Cap
41.08M
Enterprise Value
-93.08M
1-Year Change
-84.99%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $41.08M, a decrease of -82.53%. That is a compound annual growth rate of -47.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 39.19M | -79.09% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 419.89B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |